NEFROLOGÍA

Artículos

Aragoncillo Sauco I, Ligero Ramos JM, Vega Martínez A, Morales Muñoz ÁL, Abad Estébanez S, Macías Carmona N, et al. Vascular access clinic results before and after implementing a multidisciplinary approach adding routine Doppler ultrasound. Nefrologia. 2018;38(6):616-21

Baeza A, Vallet Regí M. Targeted mesoporous silica nanocarriers in oncology. Curr Drug Targets. 2018;19(3):213-24 [PubMed]

Banegas JR, Ruilope LM, De la Sierra A, Vinyoles E, Gorostidi M, De la Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378(16):1509–20 [PubMed]

Banegas JR, Ruilope LM, Williams B. Ambulatory blood pressure and mortality. N Engl J Med. 2018;379(13):1287-8

Caravaca Fontán F, Praga M. Enfermedad cardiovascular en la nefropatía lúpica: un riesgo infraestimado. Hipertens Riesgo Vasc. 2018;35(2):51–3 [PubMed]

Cavero T, Alonso M. Where are we with haemolytic uremic syndrome? Med Clin (Barc). 2018;151(8):329-35 [PubMed]

Cruzado JM, Lauzurica R, Pascual J, Marcen R, Moreso F, Gutiérrez Dalmau A, et al. Paricalcitol versus calcifediol for treating hyperparathyroidism in kidney transplant recipients. Kidney Int Rep. 2018;3(1):122-32 [PubMed]

De la Sierra A, Armario P, Oliveras A, Banegas JR, Gorostidi M, Vinyoles E, et al. Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension. J Hypertens. 2018;36(7):1563-70 [PubMed]

De la Sierra A, Banegas JR, Vinyoles E, Segura J, Gorostidi M, De la Cruz JJ, et al. Prevalence of masked hypertension in untreated and treated patients with office blood pressure below 130/80 mm Hg. Circulation. 2018;137(24):2651-3 [PubMed]

Del Pino M, Andrés A, Bernabéu AA, De Juan Rivera J, Fernández E, De Dios García Díaz J, et al. Fabry nephropathy: An evidence-based narrative review. Kidney Blood Press Res. 2018;43(2):406–21 [PubMed]

Esteras R, Martín Navarro J, Ledesma G, Fernández Prado R, Carreño G, Cintra M, et al. Incidence of hypersensitivity reactions during hemodialysis. Kidney Blood Press Res. 2018;43(5):1472-8

Fernández Juárez G, Pérez JV, Caravaca Fontán F, Quintana L, Shabaka A, Rodríguez E, et al. Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis. Clin J Am Soc Nephrol. 2018;13(12):1851-8

Fernández Ruiz M, Corbella L, Morales Cartagena A, González E, Polanco N, Ruiz Merlo T, et al. Vitamin D deficiency and infection risk in kidney transplant recipients: a single-center cohort study. Transpl Infect Dis. 2018;e12988

Fernández Ruiz M, Origüen J, Lora D, López Medrano F, González E, Polanco N, et al. Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study. Transpl Int. 2018;31(2):187–97 [PubMed]

Fernández Ruiz M, Parra P, Ruiz Merlo T, López Medrano F, San Juan R, Polanco N, et al. Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload. Transpl Infect Dis. 2018;20(1)

Fernández Ruiz M, Polanco N, García Santiago A, Muñoz R, Hernández AM, González E, et al. Impact of anti-HCV direct antiviral agents on graft function and immunosuppressive drug levels in kidney transplant recipients: a call to attention in the mid-term follow-up in a single-center cohort study. Transpl Int. 2018;31(8):887-99 [PubMed]

Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet. 2018;392(10152):1036-46

Gijón Conde T, Gorostidi M, Camafort M, Abad Cardiel M, Martín Rioboo E, Morales Olivas F, et al. Documento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial. Hipertens Riesgo Vasc. 2018 Apr 24

Goicoechea M, De Vinuesa SG, Quiroga B, Verde E, Bernis C, Morales E, et al. Aspirin for primary prevention of cardiovascular disease and renal disease progression in chronic kidney disease patients: A multicenter randomized clinical trial (AASER Study). Cardiovasc Drugs Ther. 2018;32(3):255-63

Gorostidi M, Sánchez Martínez M, Ruilope LM, Graciani A, De la Cruz JJ, Santamaría R, et al. Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factors. Nefrologia. 2018;38(6):606-15

Guerrero Hue M, Rubio Navarro A, Sevillano A, Yuste C, Gutiérrez E, Palomino Antolín A, et al. Adverse effects of the renal accumulation of haem proteins. Novel therapeutic approaches. Nefrologia. 2018;38(1):13–26 [PubMed]

Gutiérrez E, Praga M, Rivera F, Sevillano A, Yuste C, Goicoechea M, et al. Changes in the clinical presentation of immunoglobulin A nephropathy: data from the Spanish Registry of Glomerulonephritis. Nephrol Dial Transplant. 2018;33(3):472–7 [PubMed]

Huerta A, Arjona E, Portoles J, López Sánchez P, Rabasco C, Espinosa M, et al. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome. Kidney Int. 2018;93(2):450–9 [PubMed]

Jadoul M, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, et al. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Kidney Int. 2018;94(4):663-73

Lalueza A, Sanz Trepiana L, Bermejo N, Yaiza B, Morales Cartagena A, Espinosa M, et al. Risk factors for bacteremia in urinary tract infections attended in the emergency department. Intern Emerg Med. 2018;13(1):41-50 [PubMed]

Maestro de la Calle G, Fernández Ruiz M, López Medrano F, Polanco N, González E, San Juan R, et al. Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients? Atherosclerosis. 2018;269:204–10 [PubMed]

Marco H, Draibe J, Villacorta J, Quintana LF, Martín N, García-Osuna R, et al. Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement. Clin Rheumatol. 2018;37(4):1065–74 [PubMed]

Milla M, Hernández E, Mérida E, Yuste C, Rodríguez P, Praga M. Heyde syndrome: Correction of anemia after aortic valve replacement in a hemodialysis patient. Nefrologia. 2018;38(3):327-9 [PubMed]

Milla Castellanos M, Gutiérrez Martínez E, Sevillano Prieto A, Rodríguez Ramos P, Praga Terente M. Bile cast nephropathy associated with severe liver dysfunction caused by anabolic steroids. Nefrologia. 2018;38(2):221–3 [PubMed]

Molina M, Allende LM, Ramos LE, Gutiérrez E, Pleguezuelo DE, Hernández ER, et al. CD19+ B-cells, a new biomarker of mortality in hemodialysis patients. Front Immunol. 2018;9:1221

Morales E, Alonso M, Sarmiento B, Morales M. LCAT deficiency as a cause of proteinuria and corneal opacification. BMJ Case Rep. 2018 Mar 13;2018 [PubMed]

Morales JM, Serrano M, Martínez Flores JA, Gaínza FJ, Marcen R, Arias M, et al. Pretransplant IgA-anti-beta 2 glycoprotein I antibodies as a predictor of early graft thrombosis after renal transplantation in the clinical practice: A multicenter and prospective study. Front Immunol. 2018;9:468 [PubMed]

Praga M, Caravaca F, Yuste C, Cavero T, Hernández E, Morales E, et al. IgA nephropathy: What patients are at risk of progression to end-stage renal disease and how should they be treated? Nefrologia. 2018;38(4):347-52 [PubMed]

Rodríguez P, Mérida E, Hernández E, Milla M, Praga M. Hyperkalemia of non-renal origin in a hemodialysis patient. Nefrologia. 2018;38(1):96-7 [PubMed]

Rodríguez Sánchez E, Navarro García JA, Aceves Ripoll J, Álvarez Llamas G, Segura J, Barderas MG, et al. Association between renal dysfunction and metalloproteinase (MMP)-9 activity in hypertensive patients. Nefrologia. 2018 Nov 30

Rossi GP, Seccia TM, Barton M, Danser AHJ, De Leeuw PW, Dhaun N, et al. Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension. J Hypertens. 2018;36(3):451–61 [PubMed]

Rossi GP, Seccia TM, Barton M, Danser AHJ, de Leeuw PW, Dhaun N, et al. Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension. J Hypertens. 2018;36(3):462-71.

Rubio Navarro A, Sánchez Niño MD, Guerrero Hue M, García Caballero C, Gutiérrez E, Yuste C, et al. Podocytes are new cellular targets of haemoglobin-mediated renal damage. J Pathol. 2018;244(3):296–310 [PubMed]

Ruiz Hurtado G, Ruilope LM. Microvascular injury and the kidney in hypertension. Hipertens Riesgo Vasc. 2018;35(1):24–9 [PubMed]

Sandino Pérez J, Mancilla AM, Pérez Barragán E, Fernández Ruiz M. Chryseobacterium bacteraemia: a single-centre case series. Infect Dis (Lond). 2018;50(10):775-8 [PubMed]

Vincent JL, Castro P, Hunt BJ, Jörres A, Praga M, Rojas Suárez J, et al. Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies-what intensivists need to know. Crit Care. 2018;22(1):158